Scadden David bought AGIO
October 8, 2025 · Form 4 insider transaction
Scadden David bought 200 shares of Agios Pharmaceuticals, Inc. at $18.09 per share, a transaction worth $3.6K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
200
Price
$18.09
Total value
$3.6K
InsiderScadden David
Role—
SecurityCommon stock
Transaction codeM: Option exercise
Transaction dateOctober 8, 2025
Filing dateOctober 10, 2025
Shares owned after17,803
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.